Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer
Explore this paper's citation graph
- Type
- article
- Published
- 2007-05-01
- Cited by
- 28
- References
- 43
- OpenAlex
- https://openalex.org/W16955297
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:34110208
Keywords
Economics, Political science
References
- Effector memory T cells, early metastasis, and survival in colorectal cancer.
- Cancer incidence and mortality in Europe
- Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
- All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.
- Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.
- Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice.
- Resting and activated endothelial cells are increased in the peripheral blood of cancer patients.
- Retinoids Synergize with Interleukin-2 to Augment IFN-gamma and Interleukin-12 Production by Human Peripheral Blood Mononuclear Cells
- Experience with the Use of High‐Dose Interleukin‐2 in the Treatment of 652 Cancer Patients
- Lymphocyte Counts Independently Predict Overall Survival in Advanced Cancer Patients: A Biomarker for IL-2 Immunotherapy
- Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX
- Interleukin-2: inception, impact, and implications.
- Optimal two-stage designs for phase II clinical trials.
- Interleukin-2 and 13-cis retinoic acid in the treatment of minimal residual disease: a phase II study.
- Tolerance, not immunity, crucially depends on IL-2
- Global role of the immune system in identifying cancer initiation and limiting disease progression.
- Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy.
- Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial.
- Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1
- A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype.
Cited by
- Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma
- Immunotherapy for metastatic colorectal cancer: Present status and new options
- Maintenance Immunotherapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Chemoradioimmunotherapy in Locally Advanced Pancreatic and Biliary Tree Adenocarcinoma: A Multicenter Phase II Study
- Retinoic acid receptors: from molecular mechanisms to cancer therapy.
- Multicenter Phase II Study of Chemo-immunotherapy in the Treatment of Metastatic Renal Cell Carcinoma
- Immunotherapy of colorectal cancer
- Retinoic acid decorated albumin-chitosan nanoparticles for targeted delivery of doxorubicin hydrochloride in hepatocellular carcinoma
- Culture at a Higher Temperature Mildly Inhibits Cancer Cell Growth but Enhances Chemotherapeutic Effects by Inhibiting Cell-Cell Collaboration
- Immunotherapy in patients with less than complete response to chemotherapy.
- Oral isotretinoin: the most promising dermatological off-label uses
- Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion.
- Retinoid Signaling in Cancer and its Promise for Therapy
- Maintenance therapy in solid tumors
- Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
- Checkpoints and beyond - Immunotherapy in colorectal cancer.
- Tumour growth and immune evasion as targets for a new strategy in advanced cancer.
- Effect of Natural Compounds on NK Cell Activation
- Flip‐flops of natural killer cells in autoimmune diseases versus cancers: Immunologic axis
- Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
Related papers
No related papers recorded.